Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication

Eur Respir J. 2020 Sep 24;56(3):2001948. doi: 10.1183/13993003.01948-2020. Print 2020 Sep.

Abstract

ACE2 protein is expressed at high levels in the human olfactory epithelium relative to upper airway epithelial cells. This may explain COVID-19-associated olfactory dysfunction, and suggests a SARS-CoV-2 reservoir site and potential intranasal therapy. https://bit.ly/3hxT0qm

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • Coronavirus Infections / complications*
  • Coronavirus Infections / metabolism*
  • Humans
  • Olfaction Disorders / etiology*
  • Olfaction Disorders / metabolism
  • Olfactory Mucosa / metabolism*
  • Pandemics
  • Peptidyl-Dipeptidase A / metabolism*
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / metabolism*
  • SARS-CoV-2
  • Virus Replication

Substances

  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2